Revolution’s Post

Exciting IPO at PSX - Symmetry Group 1st main board listing of 2023 & 1st AI based products company to list at PSX Registrations have started from today! #SymmetryIPO #PossibilitiesTransformed #PakistanIPO #DigitalTechIPO #Topline #PakistanStockExchange

There's only one week until Inpart's exclusive webinar with DealForma CEO Chris Dokomajilar. Join us to review the 2023 year in life science partnering - the trends, the ups and downs, the rebounding M&A market, and are there hints of an IPO reboot, too? Reserve your seat today and don't miss out on all the data about all the deals, including those dropping this week at JPM. https://lnkd.in/ggvjA9qy #biopharmapartnering #openinnovation

SPAC Feed: Filament Health To Merge With SPAC To Obtain Nasdaq Listing – The Deep Dive - https://lnkd.in/ewkBRt-x Filament Health To Merge With SPAC To Obtain Nasdaq Listing  The Deep Dive Source: Filament Health To Merge With SPAC To… #SPACs #SPACNews #SPAC #IPO #markets #news #capitalmarkets #trends #goingpublic

The IPO market continues to show signs of life, and Tempus AI is the latest to file an S-1! 🚀 Tegus has you covered with: 🔍~100 transcripts covering Tempus, including 12 published within the past 2 months 📜 Direct access to the S-1 filing  📊 Tempus’ fully-drivable financial model From expert call transcripts to detailed financial models, you get everything you need to make smart decisions on a single platform from Tegus. Reach out to learn more. #IPO #Tempus #TEM #NASDAQ

IPO ALERT! Astera Labs (ALAB) came public today. The company priced its #IPO at $36. Once the shares opened they immediately spiked 50% above their $36 listing price. The company makes specialized connectivity solutions for AI data centers. This is the first major AI-related IPO of the year so this will give us insights into if investor #AI appetite is ongoing or if AI fatigue is setting in. By the massive 50% jump in the shares, so far, investors AI appetite seems to be intact. But time will tell. #Stocks #stockmarket #stock #Nvidia

PNBN Trending News: 2023 in Review: Region’s first life sciences IPO since 2021 tops industry’s biggest raises of the year https://lnkd.in/gerYc6N8 Despite economic headwinds, this year saw the region’s first life sciences IPO since 2021. Click here to view original post Click here to view Pennsylvania NY/NJ Biotech Networks Trending News

Are you ready for the summer?   ‘Next wave of IPOs’ will arrive in summer, predicts biotech-focused VC partner   Medicxi's Francesco De Rubertis (second from right) spoke to Fierce Biotech after participating in a panel at the LSX World Conference on how biotechs can prepare for an IPO. (James Waldron) Delegates at the LSX World Conference in London this week seemed to agree on one thing—the biotech IPO window finally re-opened this year.   https://lnkd.in/e-zp2tkQ   #ipo #listings #securities #srfc 

At Nasdaq right now for the Sofinnova Investments & KKH Advisors Life Sciences Summit. The event kicked off with a great first panel “Current Biotech IPO Landscape Update”, moderated by Kimberly Ha, CEO, KKH Advisors with panelists, Jordan Saxe (Nasdaq), Paul Scansaroli, (Piper Sandler), Joshua Thomas (Altium Capital) and Chirag Surti (Morgan Stanley). Summarizing some really good advice for companies considering an #IPO: - A strong crossover round with enthusiastic investors sets an important base for a successful IPO: important for existing investors to fully cover base deal size at time of IPO launch. - Being a public company is a 2nd job, important to sufficiently prepare and start acting/thinking like a public company well in advance of IPO.  -  Validating partnerships and licensing agreements help prove attractiveness for future M&A perspective. Important to continue these strategic discussions in parallel to IPO prep. 

Sensex Today | Stock Market LIVE Updates: Cello World IPO subscribed 13% so far on Day 1. Check GMP and other details The initial public offer (IPO) of Cello World was subscribed 13% so far on the first day of the bidding process. The non-institutional investor (NII) category was booked 25%, while that of retail investors was subscribed 16%. There were no bids from the QIB category yet. Most analysts advised investors to subscribe to the IPO over the company's strong brand identity and diverse product portfolio across different categories.

💨 Momentum for US #ipos is picking up 🏃♂️ According to Goldman Sachs, the best is yet to come for the new issues market. 😍 With Workiva, issuers & advisors can work together during #IPO drafting sessions within the platform - you always have access to the latest version of the document, without waiting for files to come back from a printer. 💥 👀 See how Weave knew Workiva had the right solution for working through their IPO. 👉 https://lnkd.in/eUC8amJ4 #capitalmarkets #customertestimonial #digitaltransformation #workiva https://lnkd.in/eP3wPDZe